Yes, a postpartum woman with a reactive RPR test should be treated with benzathine penicillin G.
A recently delivered patient with a reactive RPR screening test should receive benzathine penicillin G treatment immediately, with the specific regimen determined by the stage of syphilis. The postpartum period does not contraindicate treatment—in fact, prompt treatment remains critical even after delivery to prevent ongoing maternal complications and to reduce transmission risk to future contacts 1.
Treatment Approach
Immediate Steps
Confirm the diagnosis: A reactive RPR should be confirmed with a treponemal test if not already done. However, treatment should not be delayed if the patient is seropositive without documented adequate prior treatment 1, 2.
Determine the stage of syphilis: Review the patient's history for:
- Symptoms or signs of primary/secondary syphilis (chancre, rash, lymphadenopathy)
- Duration of infection if known
- Previous treatment history and serologic response
- RPR titer levels
Assess treatment history: The patient should be considered infected unless adequate treatment is clearly documented with appropriate serologic decline 1.
Treatment Regimens
For primary, secondary, or early latent syphilis:
- Benzathine penicillin G 2.4 million units IM as a single dose 1
- Some experts recommend a second dose of 2.4 million units IM one week later, particularly for women who had secondary syphilis during pregnancy 1, 2
For late latent syphilis or syphilis of unknown duration:
- Benzathine penicillin G 7.2 million units total, administered as 2.4 million units IM weekly for three consecutive weeks 1
For HIV-infected patients:
- Follow the same regimens as above, but consider CSF examination before treatment for late latent or unknown duration syphilis 1
Critical Considerations for Postpartum Treatment
Infant Evaluation
Even though the mother is now postpartum, the infant requires immediate evaluation if the mother was not adequately treated during pregnancy or if treatment occurred late in pregnancy 1, 3. The infant should undergo:
- Physical examination for signs of congenital syphilis
- Quantitative nontreponemal serologic testing (RPR or VDRL)
- Complete blood count with differential and platelet count
- CSF analysis if indicated
- Long-bone radiographs if symptomatic
Breastfeeding
Penicillin G is excreted in breast milk, but this should not prevent treatment. Caution should be exercised, but treatment should proceed as the benefits far outweigh theoretical risks 4. The mother can continue breastfeeding unless she has active syphilitic lesions on the breast.
Follow-up Monitoring
Serologic titers should be monitored monthly initially to ensure adequate treatment response 2. For early syphilis, expect at least a fourfold decline in RPR titers within 6-12 months. If titers do not decline appropriately, consider:
- Re-treatment with the extended regimen (7.2 million units over 3 weeks)
- CSF examination to rule out neurosyphilis
- HIV testing if not already performed 1
Common Pitfalls to Avoid
Do not delay treatment waiting for confirmatory testing or staging workup—treat based on reactive RPR if the patient lacks documented adequate prior treatment 1.
Do not use alternative antibiotics in the postpartum period. Penicillin remains the only proven effective treatment. If the patient reports penicillin allergy, perform skin testing and desensitize if necessary 1, 2.
Do not assume the infant is unaffected just because treatment is being given postpartum. The infant requires separate evaluation and possible treatment 3.
Do not forget partner notification and treatment. Sexual contacts within the past 90 days (for primary syphilis) or 6 months (for secondary syphilis) should be evaluated and treated 1.
The evidence consistently supports benzathine penicillin G as the treatment of choice across all CDC guidelines 1, 2, 1, with FDA approval for this indication 4. Recent research continues to support its efficacy, though combination therapy with doxycycline may improve serologic responses in HIV-positive patients 5.